GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Botanix Pharmaceuticals Ltd (ASX:BOT) » Definitions » Sale Of Business

Botanix Pharmaceuticals (ASX:BOT) Sale Of Business : A$0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 1985. Start your Free Trial

What is Botanix Pharmaceuticals Sale Of Business?

Botanix Pharmaceuticals's sale of business for the six months ended in Dec. 2023 was A$0.00 Mil. It means Botanix Pharmaceuticals gained A$0.00 Mil from selling business. Botanix Pharmaceuticals's sale of business for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.00 Mil.

Compared with last quarter (A$0.00 Mil in Jun. 2023 ), Botanix Pharmaceuticals gained the same money from selling business in Dec. 2023 (A$0.00 Mil).

Botanix Pharmaceuticals Sale Of Business Historical Data

The historical data trend for Botanix Pharmaceuticals's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Botanix Pharmaceuticals Sale Of Business Chart

Botanix Pharmaceuticals Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Sale Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Botanix Pharmaceuticals Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Sale Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Botanix Pharmaceuticals Sale Of Business Calculation

The amount earned to sell business.


Sale Of Business for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Botanix Pharmaceuticals Sale Of Business Related Terms

Thank you for viewing the detailed overview of Botanix Pharmaceuticals's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Botanix Pharmaceuticals (ASX:BOT) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Botanix Pharmaceuticals Ltd (ASX:BOT) » Definitions » Sale Of Business
Comparable Companies
ASX:PYC ASX:OPT ASX:RAC ASX:DXB ASX:IMM ASX:PIQ ASX:RCE ASX:ALA ASX:PAA ASX:PAR OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX
Traded in Other Exchanges
BXPHF:USA
Address
661 Newcastle Street, D2, LEEDERVILLE, WA, AUS, 6007
Website
https://www.botanixpharma.com
Botanix Pharmaceuticals Ltd is a clinical-stage cannabinoid therapeutics company. The company's focus is the development of safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system - Permetrex for direct skin delivery of active pharmaceuticals in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1308 - Plaque Psoriasis, BTX1204 - Atopic Dermatitis, and BTX 1701 - Mild Acne. The majority of Revenue is Derived from Australia.

Botanix Pharmaceuticals (ASX:BOT) Headlines

No Headlines